Skip to main content
Clinical Trials/NCT03621943
NCT03621943
Completed
Not Applicable

Umbilical Cord Milking in Non-Vigorous Infants Developmental Followup (MINVIFU)

Sharp HealthCare10 sites in 3 countries1,207 target enrollmentJanuary 7, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Neurodevelopmental Abnormality
Sponsor
Sharp HealthCare
Enrollment
1207
Locations
10
Primary Endpoint
Total and Domain Scores on the Ages and Stages Questionnaire, Third Edition.
Status
Completed
Last Updated
last year

Overview

Brief Summary

A sub-study to evaluate longer-term developmental outcomes in non-vigorous term and near-term newborns who receive umbilical cord milking in comparison to those who undergo early cord clamping at delivery.

Detailed Description

This sub-study investigates the potential difference in neurodevelopmental outcomes during early childhood between newborns who undergo umbilical cord milking and those who experience early cord clamping at birth. The developmental progress of participants is evaluated using the Ages and Stages Questionnaire-3 which measures five developmental areas: communication, problem-solving, fine motor skills, gross motor skills, and personal-social behavior. Additionally, the Modified Checklist for Autism in Toddlers is employed as a secondary assessment. The recruitment of participants is conducted through the primary study Umbilical Cord Milking in Nonvigorous Infants trial (NCT03631940) with the method of umbilical cord management for each newborn being dictated by the randomized treatment allocation of the primary study.

Registry
clinicaltrials.gov
Start Date
January 7, 2019
End Date
September 26, 2023
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Anup Katheria, M.D.

Director, Neonatal Research Institute

Sharp HealthCare

Eligibility Criteria

Inclusion Criteria

  • Enrolled in the primary trial NCT:03631940 and parental written consent to participate in developmental follow-up through 2 years of age was obtained.
  • Enrolled in the primary trial NCT:03631940 and did not survive to 2 years.

Exclusion Criteria

  • Enrolled in the primary trial NCT:03631940 but parent/guardian declined consent to developmental follow-up participation.

Outcomes

Primary Outcomes

Total and Domain Scores on the Ages and Stages Questionnaire, Third Edition.

Time Frame: 22 to 26 months

Neurodevelopmental Outcome at 2 Years of Age defined as overall and domain scores on the Ages and Stages, third edition. Questionnaire. Minimum score of 0 and maximum score of 60 per domain. Scores from 5 subscales are summed to obtain a total score. 5 domains assessed include communication, gross motor, fine motor, problem solving, personal social with a total minimum score of 0 and maximum score of 300. Higher scores indicate a lower risk of developmental delays or conditions

Secondary Outcomes

  • Score Ranges on the Modified Checklist for Autism in Toddlers Questionnaire(22-26 months)

Study Sites (10)

Loading locations...

Similar Trials